Denali Therapeutics Q3 EPS $(0.48) Down From $(0.38) YoY, Sales $13.604M Up From $1.195M YoY

Denali Therapeutics (NASDAQ:DNLI) reported quarterly losses of $(0.48) per share. This is a 26.32 percent decrease over losses of $(0.38) per share from the same period last year. The company reported $13.604 million in

Benzinga · 11/06/2019 22:20

Denali Therapeutics (NASDAQ:DNLI) reported quarterly losses of $(0.48) per share. This is a 26.32 percent decrease over losses of $(0.38) per share from the same period last year. The company reported $13.604 million in sales this quarter. This is a 1.04K percent increase over sales of $1.195 million the same period last year.